Dr. Bahija Jallal - Articles and news items


MedImmune and Incyte announce collaboration on immuno-oncology combination clinical trial

Industry news / 14 May 2014 / AstraZeneca

AstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a clinical study collaboration with biopharmaceutical company Incyte Corporation…


AstraZeneca oncology portfolio strengthened as MedImmune acquisition of Spirogen boosts antibody-drug conjugate capability

Industry news / 15 October 2013 / AstraZeneca

Additional investment in and collaboration with ADC Therapeutics…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...